Clinical Trial Update: Prophylactic Treatment of Skin Rash Associated With EGFR Inhibitor Therapy [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating prophylactic treatment for skin rash caused by EGFR inhibitor therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Egfr Inhibitor-induced Skin Rash

Snippet

Sponsor: TWi Biotechnology, Inc. | Conditions: EGFR Inhibitor-Induced Skin Rash | Phase 2 | Status: COMPLETED